Skip to main content
Toggle navigation
Login
Search
Home
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
B
B Ximenez, Joao Paulo
University of Sao Paulo
PII-038
-
PK/PD OF RIFAMPICIN, ISONIAZID, PYRAZINAMIDE, AND ETHAMBUTOL IN MACROPHAGES INFECTED WITH M. TUBERCULOSIS.
Joao Paulo B Ximenez
Favorite
Back, Hyunmoon
Bristol Myers Squibb
PII-095
-
A POPULATION PHARMACOKINETIC (PK) MODEL OF MILVEXIAN, A SMALL MOLECULE FACTOR XIA INHIBITOR, IN HEALTHY VOLUNTEERS.
Hyunmoon Back
Favorite
Bader, Justin
Bicycle Therapeutics
CT-012
-
PHARMACOKINETICS OF BT8009, A BICYCLE TOXIN CONJUGATE (BTC), IN PATIENTS WITH SOLID TUMOR MALIGNANCIES AND VARIOUS DEGREES OF RENAL FUNCTIONS
Justin Bader
Favorite
PII-062
-
PHARMACOKINETICS OF BT8009, A BICYCLE TOXIN CONJUGATE (BTC), IN PATIENTS WITH SOLID TUMOR MALIGNANCIES AND VARIOUS DEGREES OF RENAL FUNCTIONS
Justin Bader
Favorite
Bae, Jihyun
FDA
PII-186
-
A SURVEY ON RECOMMENDATION OF FOOD CONDITIONS IN BIOEQUIVALENCE STUDIES WITH PHARMACOKINETIC ENDPOINTS FOR GENERIC ORAL ANTINEOPLASTIC DRUG DEVELOPMENT.
Jihyun Bae
Favorite
Baek, Seunghwan
Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Bundang Hospital
CT-008
-
EFFICACY AND SAFETY OF METFORMIN IN TYPE 2 DIABETIC PATIENTS WITH MILD HEPATIC IMPAIRMENTS: A RETROSPECTIVE COHORT STUDY USING PROPENSITY SCORE MATCHING METHOD.
Seunghwan Baek
Favorite
PII-201
-
EFFICACY AND SAFETY OF METFORMIN IN TYPE 2 DIABETIC PATIENTS WITH MILD HEPATIC IMPAIRMENTS: A RETROSPECTIVE COHORT STUDY USING PROPENSITY SCORE MATCHING METHOD.
Seunghwan Baek
Favorite
Balazki, Pavel
esqlabs GmbH
PII-165
-
AUTOMATED QUALIFICATION FRAMEWORK FOR PHYSIOLOGICALLY-BASED QUANTITATIVE SYSTEMS PHARMACOLOGY MODELING
Pavel Balazki
Favorite
Barry, Jessica
University of Minnesota
PII-208
-
UTILIZING STATISTICAL OR POPULATION PHARMACOKINETIC BASED MATCHING FOR VIRTUAL CONTROL GROUPS IN RENAL AND HEPATIC IMPAIRMENT STUDIES
Jessica Barry
Favorite
Bedathuru, Dinesh
Vantage Research
PII-218
-
QSP MODEL OF RHEUMATOID ARTHRITIS, CAPTURING RANGE OF RESPONSES TO METHOTREXATE, ADALIMUMAB AND TOCILIZUMAB THERAPIES
Dinesh Bedathuru
Favorite
Bhamidipaty-Pelosi, Surya
Indiana University
TIP-004
-
CHARACTERIZATION OF LABETALOL IN PREGNANCY (THE CLIP STUDY).
Surya Bhamidipaty-Pelosi
Favorite
Bhat, Laxminarayan
Reviva Pharmaceuticals Holdings Inc
LB-008
-
BRILAROXAZINE EFFICACY AND SAFETY IN THE PHASE 3 RECOVER TRIAL IN ACUTE SCHIZOPHRENIA
Laxminarayan Bhat
Favorite
Bhatnagar, Roopal
Critical Path Institute
AI-004
-
UNLOCKING HIDDEN DRUG-REPURPOSING OPPORTUNITIES: NLP-POWERED TOPIC MODELING OF UNSTRUCTURED CURE-ID DATA
Roopal Bhatnagar
Favorite
PII-225
-
UNLOCKING HIDDEN DRUG-REPURPOSING OPPORTUNITIES: NLP-POWERED TOPIC MODELING OF UNSTRUCTURED CURE-ID DATA
Roopal Bhatnagar
Favorite
Bravo Padros, Marçal
Regeneron Pharmaceuticals, Inc.
PII-067
-
POPULATION PHARMACOKINETICS OF ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA.
Marçal Bravo Padros
Favorite
Burnett, Joseph
Bristol Myers Squibb
PII-178
-
PROSPECTIVE APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING TO INFORM THE DESIGN OF A CLINICAL DRUG-DRUG INTERACTION (DDI) STUDY: CASE STUDY OF MEZIGDOMIDE
Joseph Burnett
Favorite
